Search Records

Health Canada and the Canadian Advertising Preclearance Agencies (APAs) share the common goal of maintaining integrity in health product advertising. The purpose of this guidance document is to inform staff and stakeholders of the different roles these organizations play in achieving this goal.

This strategy document outlines the steps to be taken in order to optimize the use of RWE to improve the safety and effectiveness of medical devices across the product life cycle. As well, the plan describes the activities and the outputs required to achieve the objectives.

On April 28, 2016, Health Canada, the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the New Zealand Ministry for Primary Industries (NZMPI) simultaneously approved a new use for pain relief in sheep for the veterinary drug Metacam.

Part of Health Canada’s work as a regulator is to engage and inform Canadians on issues about their health. Learn how we use consultations and other tools to help protect and improve the health of Canadians.

At Health Canada our role is to help Canadians maintain and improve their health. While the provinces and territories are responsible for delivering healthcare to the majority of Canadians, the federal government also has a number of key roles and responsibilities in areas that affect health and...

President meeting with Mr. Stephen Lucas, Deputy Minister, Health Canada, October 11, 2019

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines...

Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative...

The Public Health Agency of Canada’s National Microbiology Lab (PHAC-NML) will conduct independent scientific laboratory evaluation of some COVID-19 testing devices when requested by Health Canada.